SYNVIVIA, INC.
BERKELEY, CA · CIK 0002003070 · Biotech · Private
Chemically-controlled essential genes and protein engineering platform for GMO containment
synvivia.com →- Grants
- $3.0M
- 4 awards
- Sector median: 1
- Raised
- $54K
- 1 Form D · Dec 2023
- 34 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 0 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Genetically Encoded Biosafety in a Therapeutically Modified Organism for Obesity | $295,172 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I:Development of a Novel Biocontainment/Biosafety Platform Using Synthetic Auxotrophs | $255,910 | |
| Private capital raised | Form D · SEC | $54,096 | |
| Federal grant | Department of Health and Human Services · Phase II · Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes | $1,640,169 | |
| Federal grant | Department of Health and Human Services · Phase II · Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes | $856,268 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1229 | Gaingels LabGenius LLC | — | $64K |
| 1230 | EZRABIO INC. | — | — |
| 1231 | Gaius Therapeutics, Inc, | — | $60K |
| 1232 | SYNVIVIA, INC. | — | $54K |
| 1233 | Artemis Biosystems, Inc. | — | $50K |
| 1234 | Factor Medical, LLC | — | $50K |
| 1235 | Auvi Labs, Inc. | — | $543K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Gabriel LopezDirector · Executive Officer
Patents
- Engineered Cyclic Peptides For Enhancing Viral Productionapplication
- Synthetic Helper Genes For Enhancing Viral Productionapplication
- Synthetic Helper Genes For Enhancing Viral Productionapplication
- Methods Of Selection And Use Of Engineered Cyclic Peptides For Enhancing Viral Productionapplication
- Methods Of Selection And Use Of Engineered Cyclic Peptides For Enhancing Aav Productionapplication
- Synthetic Helper Genes For Enhancing Viral Productionapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.